These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15135700)

  • 1. Role of adenosine monophosphate deaminase-1 gene polymorphism in patients with congestive heart failure (influence on tumor necrosis factor-alpha level and outcome).
    Gastmann A; Sigusch HH; Henke A; Reinhardt D; Surber R; Gastmann O; Figulla HR
    Am J Cardiol; 2004 May; 93(10):1260-4. PubMed ID: 15135700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AMPD1 (C34T) polymorphism and clinical outcomes in patients undergoing myocardial revascularization.
    Andreassi MG; Botto N; Laghi-Pasini F; Manfredi S; Ghelarducci B; Farneti A; Solinas M; Biagini A; Picano E
    Int J Cardiol; 2005 May; 101(2):191-5. PubMed ID: 15882662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of AMPD1 C34T genotype as a predictor of mortality in heart failure and post-myocardial infarction patients.
    Collins RP; Palmer BR; Pilbrow AP; Frampton CM; Troughton RW; Yandle TG; Skelton L; Richards AM; Cameron VA
    Am Heart J; 2006 Aug; 152(2):312-20. PubMed ID: 16875916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common variant in AMPD1 gene predicts improved clinical outcome in patients with heart failure.
    Loh E; Rebbeck TR; Mahoney PD; DeNofrio D; Swain JL; Holmes EW
    Circulation; 1999 Mar; 99(11):1422-5. PubMed ID: 10086964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of the AMPD1 gene polymorphism on exercise capacity, other prognostic parameters, and survival in patients with stable congestive heart failure: a study in 686 consecutive patients.
    de Groote P; Lamblin N; Helbecque N; Mouquet F; Hermant X; Amouyel P; Dallongeville J; Bauters C
    Am Heart J; 2006 Oct; 152(4):736-41. PubMed ID: 16996850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of a common adenosine monophosphate deaminase (AMPD)-1 polymorphism in outcomes of ischemic and nonischemic heart failure.
    Kolek MJ; Carlquist JF; Thaneemit-Chen S; Lazzeroni LC; Whiting BM; Horne BD; Muhlestein JB; Lavori P; Anderson JL
    J Card Fail; 2005 Dec; 11(9):677-83. PubMed ID: 16360962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of adenosine monophosphate deaminase-1 C34T allele on the requirement for donor inotropic support and on the incidence of early graft dysfunction after cardiac transplantation.
    Taegtmeyer AB; Breen JB; Rogers P; Johnson PH; Smith J; Smolenski RT; Banner NR; Yacoub MH; Barton PJ
    Am J Cardiol; 2009 May; 103(10):1457-62. PubMed ID: 19427446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of the AMPD1 gene polymorphism on exercise capacity, other prognostic parameters, and survival in patients with stable congestive heart failure. A study on 686 consecutive patients.
    de Groote P; Mouquet F; Dallongeville J; Lamblin N; Bauters C
    Am Heart J; 2007 May; 153(5):e15. PubMed ID: 17452135
    [No Abstract]   [Full Text] [Related]  

  • 9. AMPD1 gene polymorphism and survival in patients with stable congestive heart failure.
    Palmer BR; Frampton CM; Richards AM; Cameron VA
    Am Heart J; 2007 May; 153(5):e13. PubMed ID: 17452134
    [No Abstract]   [Full Text] [Related]  

  • 10. TNF-alpha gene 1031 T/C polymorphism in Turkish patients with Behçet's disease.
    Akman A; Sallakci N; Coskun M; Bacanli A; Yavuzer U; Alpsoy E; Yegin O
    Br J Dermatol; 2006 Aug; 155(2):350-6. PubMed ID: 16882174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing Type D personality and older age as correlates of tumor necrosis factor-alpha dysregulation in chronic heart failure.
    Denollet J; Vrints CJ; Conraads VM
    Brain Behav Immun; 2008 Jul; 22(5):736-43. PubMed ID: 18068948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma concentrations of TNF-alpha and its soluble receptors sTNFR1 and sTNFR2 in patients with coronary artery disease.
    Safranow K; Dziedziejko V; Rzeuski R; Czyzycka E; Wojtarowicz A; Bińczak-Kuleta A; Jakubowska K; Olszewska M; Ciechanowicz A; Kornacewicz-Jach Z; Machaliński B; Pawlik A; Chlubek D
    Tissue Antigens; 2009 Nov; 74(5):386-92. PubMed ID: 19845893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetics of humoral and cytokine activation in heart failure and its importance for risk stratification of patients.
    Spinarová L; Spinar J; Vasků A; Pávková-Goldbergová M; Ludka O; Tomandl J; Vítovec J
    Exp Mol Pathol; 2008 Jun; 84(3):251-5. PubMed ID: 18442814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between tumor necrosis factor (TNF)-alpha G-308A gene polymorphism and preeclampsia complicated by severe fetal growth restriction.
    Molvarec A; Jermendy A; Nagy B; Kovács M; Várkonyi T; Hupuczi P; Prohászka Z; Rigó J
    Clin Chim Acta; 2008 Jun; 392(1-2):52-7. PubMed ID: 18396154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A common variant of the AMPD1 gene predicts improved cardiovascular survival in patients with coronary artery disease.
    Anderson JL; Habashi J; Carlquist JF; Muhlestein JB; Horne BD; Bair TL; Pearson RR; Hart N
    J Am Coll Cardiol; 2000 Oct; 36(4):1248-52. PubMed ID: 11028479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between AMPD1 gene polymorphism and coagulation factors in patients with coronary heart disease.
    Agewall S; Norman B
    Pathophysiol Haemost Thromb; 2006; 35(6):440-4. PubMed ID: 17565237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tumor necrosis factor polymorphism TNF (-308) is associated with susceptibility to meningococcal sepsis, but not with lethality.
    Read RC; Teare DM; Pridmore AC; Naylor SC; Timms JM; Kaczmarski EB; Borrow R; Wilson AG
    Crit Care Med; 2009 Apr; 37(4):1237-43. PubMed ID: 19242354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of bladder tumors and GA genotype of -308 nucleotide in tumor necrosis factor-alpha promoter with greater tumor necrosis factor-alpha expression.
    Jeong P; Kim EJ; Kim EG; Byun SS; Kim CS; Kim WJ
    Urology; 2004 Nov; 64(5):1052-6. PubMed ID: 15533517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type D personality is associated with increased levels of tumour necrosis factor (TNF)-alpha and TNF-alpha receptors in chronic heart failure.
    Conraads VM; Denollet J; De Clerck LS; Stevens WJ; Bridts C; Vrints CJ
    Int J Cardiol; 2006 Oct; 113(1):34-8. PubMed ID: 16325284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetic interactions between angiotensin-converting enzyme inhibitor therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure.
    McNamara DM; Holubkov R; Postava L; Janosko K; MacGowan GA; Mathier M; Murali S; Feldman AM; London B
    J Am Coll Cardiol; 2004 Nov; 44(10):2019-26. PubMed ID: 15542286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.